All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese

Obesity

Volumn 16, Issue 3, 2008, Pages 684-689

  Huang, Kuo Chin ^a   Lee, Long Teng ^a   Chen, Ching Yu ^a   Sung, Pei Kun ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MJ Health Screening Center   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NOMENCLATURE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICS; TAIWAN; TIME;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TAIWAN; TERMINOLOGY AS TOPIC; TIME FACTORS;

EID: 40149106783     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.112     Document Type: Article

References (33)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
2. Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-2846.
3. Liu J, Grundy SM, Wang W et al. Ethnic-specific criteria for the metabolic syndrome: evidence from China. Diabetes Care 2006;29:1414-1416.
4. Haffner SM, Valdez RA, Hazuda HP et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
5. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
6. Laaksonen DE, Lakka HM, Niskanen LK et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-1077.
7. Lorenzo C, Okoloise M, Williams K, Stern MR Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003;26:3153-3159.
8. Dekker JM, Girman C, Rhodes T et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112:666-673.
9. McNeill AM, Rosamond WD, Girman CJ et al. The metabolic syndrome and 11 -year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28:385-390.
10. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072.
11. Kurl S, Laukkanen JA, Niskanen L et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006;37:806-811.
12. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
13. Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-1250.
14. Hu G, Qiao Q, Tuomilehto J et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-1076.
15. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251-1257.
16. Shen YH, Yang WS, Lee TH et al. Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults. Obes res 2005;13:1238-1245.
17. Huang KC, Lin WY, Lee LT et al. Four anthropometric indices and cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002;26:1060-1068.
18. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-2752.
19. Alberti KG, Zimmet R Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
20. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749.
21. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-1778.
22. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-819.
23. Patel A, Huang KC, Janus ED et al. Is a single definition of the metabolic syndrome appropriate? - a comparative study of the USA and Asia. Atherosclerosis 2006;184:225-232.
24. Chen HJ, Pan WH. Probable blind spot in the International Diabetes Federation definition of metabolic syndrome. Obesity 2007;15:1096-1100.
25. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
26. Sundstrom J, Riserus U, Byberg L et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. SMJ 2006;332:878-882.
27. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89:2583-2589.
28. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105.
29. Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-778.
30. Jee SH, Sull JW, Park J et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006;355:779-787.
31. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 2006;37:1060-1064.
32. Hong Y, Jin X, Mo J et al. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality-results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med 2007;262:113-122.
33. Guize L, Thomas F, Pannier B et al. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 2007;30:2381-2387.